Alto Pharmacy Stock

Patient-centric pharmacy.

About Alto Pharmacy Stock

Alto, formerly ScriptDash, is a digital pharmacy company that offers doctors and clinics an easier back-end system to fill those prescriptions. Its platform helps doctors and pharmacies coordinate and communicate to each other easily. Alto so far has delivered more than 100,000 prescriptions to 12,000 patients living in the San Francisco Bay Area since launching in June of 2015.

Funding History

June 2015	$0
June 2016	$6.0M
June 2017	$17.0M
December 2018	$50.0M

Management

CEO

Mattieu Gamache-Asselin

Director, Strategic Partnerships

Luke Diaz

Software Engineer

Alex Toombs

Co Founder & CTO

Jamie Karraker

Head of Growth

Ian Thiel

Press

These 50 Start-Ups May Be the Next ‘Unicorns’

New York Times - Feb, 10 2019

Other Companies

Learn More

Crowdcast

Crowdcast helps you have meaningful live interactions with your audience.

$0Total Funding

Learn More

DionyMed Holdings

DionyMed Holdings distributes critical component products.

$0Total Funding

Learn More

Trōv

On-Demand insurance platform

$98.8MTotal Funding

Learn More

Two Pore Guys, Inc.

Hand-held, low cost, single molecule biosensor -- accurate and precise as medical equipment; as easy to use as a glucose monitor

$29.7MTotal Funding

EquityZen does not have an affiliation with, formal relationship with, or endorsement from Alto Pharmacy or any companies feature above. This profile is based on publicly available information and is intended to be informative in nature.

Some data provided by Crunchbase

Trending Companies

Join 80K+ Investors and Shareholders

On our trusted digital marketplace for private companies

EquityZen Recognized As:

Why EquityZen?

EquityZen helps investors to access private companies and their employees to sell shares.

Investment opportunities posted on this website are "private placements" of securities that are not publicly traded, are subject to holding period requirements, and are intended for investors who do not need a liquid investment. Investing in private companies may be considered highly speculative and involves a high degree of risk, including the risk of substantial loss of investment. Investors must be able to afford the loss of their entire investment. See our Risk Factors for a more detailed explanation of the risks involved by investing through EquityZen’s platform.

EquityZen Securities LLC (“EquityZen Securities”) is a subsidiary of EquityZen Inc. EquityZen Securities is a broker/dealer registered with the Securities Exchange Commission and is a FINRA/SIPC member firm.

Equity securities are offered through EquityZen Securities. Check the background of this firm on FINRA’s BrokerCheck.

EquityZen.com is a website operated by EquityZen Inc. ("EquityZen"). By accessing this site and any pages thereof, you agree to be bound by our Terms of Use.
EquityZen and logo are trademarks of EquityZen Inc. Other trademarks are property of their respective owners.
© 2020 EquityZen Inc. All rights reserved.